FIGS INC. CL.A DL-,0001

At the Barclays conference FIGS said it expects about $760m in revenue for the current year (+20%) and an adjusted EBITDA margin of 15%. The active customer base rose to 3.1 million and international revenue grew 67% in the quarter, while non‑scrubwear categories increased by 40%. Management emphasized larger competitive advantages but sees near‑term margin pressure from duty refunds and rising freight costs. » More on de.investing.com

FIGS has specialized in clothing for medical professionals and leads the Apparel Manufacturing sector with a share price gain of over 54%. The company recorded revenue growth of more than 25% for the third consecutive quarter. In addition, the margin rose by over 8%, mainly due to duty refunds. » More on finanzen.net

FIGS reported a strong Q1 with revenue of $159.9 million, up 28% year‑over‑year, U.S. revenue up 24% to $131.6 million and international revenue up 50% to $28.3 million. Active customers surpassed 3 million, up 12% year‑over‑year, and growth was broad‑based across products and regions. Despite the results, shares slipped largely due to investor positioning; the stock closed at $14.49 with a market cap of $2.41 billion and has risen 109.09% over the past 52 weeks. Baron Focused Growth Fund reiterated conviction in FIGS' direct‑to‑consumer model and market‑share potential. » More on finance.yahoo.com

Figs reported Q2 sales up 29% to $196.6 million and GAAP net profit up about 300% year over year, with free cash flow turning positive at roughly $97 million over the past 12 months. The stock jumped about 27% on earnings and continued rising, while analysts at Barclays and KeyBanc raised price targets to $20 and Telsey lowered its target to $16. Figs trades at about 38x P/E but around 22x on an enterprise-value-to-FCF basis, a valuation the article argues is attractive given current growth rates. » More on finance.yahoo.com

Figs reported adjusted EPS of $0.15 and revenue of $196.6 million for Q2 2026, both well above consensus estimates. Management raised its full‑year growth forecast to around 20% and expanded the share buyback program by $100 million. Gross margin rose to 75.2% and operating margin to 17.9%; free cash flow turned positive and active customers grew to 3.1 million. The stock jumped about 27.7% in premarket trading. » More on de.investing.com